Bovine leukemia virus: current perspectives

References

• Maclachlan NJ, Dubovi EJ. Retroviridae. In: Press A, editor. Fenner’s Veterinary Virology. 4th ed: Elsevier Science; 2011:243–274.
   Google Scholar
• Barbeau B, Hiscott J, Bazarbachi A, et al. Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26–30 June 2013, Montreal, Canada. Retrovirology. 2014;11:19.
   Google Scholar
• Schwartz I, Levy D. Pathobiology of bovine leukemia virus. Vet Res. 1994;25(6):521–536.
   Web of Science ®Google Scholar
• USDA. Bovine Leukosis Virus (BLV) on U.S. Dairy Operations, 2007; 2008.
   Google Scholar
• Bauermann FV, Ridpath JF, Dargatz DA. Bovine leukemia virus seroprevalence among cattle presented for slaughter in the United States. J Vet Diagn Invest. 2017.
   Web of Science ®Google Scholar
• Samagh BS, Kellar JA. Seroepidemiological survey of bovine leukaemia virus infection in Canadian cattle. Paper presented at: Fourth International Symposium on Bovine Leukosis; 1982; Luxembourg.
   Google Scholar
• Trono KG, Perez-Filgueira DM, Duffy S, Borca MV, Carrillo C. Seroprevalence of bovine leukemia virus in dairy cattle in Argentina: comparison of sensitivity and specificity of different detection methods. Vet Microbiol. 2001;83(3):235–248.
   Web of Science ®Google Scholar
• European Commission. Bovine and swine diseases. Annual Report. 2014.
   Google Scholar
• Voges H. Reports from Industry Surveillance and Disease Control Programmes: New Zealand Dairy Enzootic Bovine Leukosis (EBL) Control Scheme SURVEILLANCE 38 37. 2011. Available from http://www.sciquest.org.nz/elibrary/download/72863/New_Zealand_Dairy_Enzootic_Bovine_Leukosis_%28EBL%29_C.pdf? Accessed July 11, 2017.
   Google Scholar
• Lairmore MD. Animal models of bovine leukemia virus and human T-lymphotrophic virus type-1: insights in transmission and pathogenesis. Annu Rev Anim Biosci. 2014;2:189–208.
   Web of Science ®Google Scholar
• Willems L, Kerkhofs P, Dequiedt F, et al. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc Natl Acad Sci U S A. 1994;91(24):11532–11536.
   Web of Science ®Google Scholar
• Kincaid RP, Burke JM, Sullivan CS. RNA virus microRNA that mimics a B-cell oncomiR. Proc Natl Acad Sci U SA. 2012;109(8):3077–3082.
   PubMed Web of Science ®Google Scholar
• Rosewick N, Momont M, Durkin K, et al. Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma. Proc Natl Acad Sci U S A. 2013;110(6):2306–2311.
   PubMed Web of Science ®Google Scholar
• Gillet NA, Hamaidia M, de Brogniez A, et al. Bovine leukemia virus small noncoding RNAs are functional elements that regulate replication and contribute to oncogenesis in vivo. PLoS Pathog. 2016;12(4):e1005588.
   PubMed Web of Science ®Google Scholar
• Durkin K, Rosewick N, Artesi M, et al. Characterization of novel bovine leukemia virus (BLV) antisense transcripts by deep sequencing reveals constitutive expression in tumors and transcriptional interaction with viral microRNAs. Retrovirology. 2016;13(1):33.
   PubMedGoogle Scholar
• Rosewick N, Durkin K, Artesi M, et al. Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis. Nat Commun. 2017;8:15264.
   PubMed Web of Science ®Google Scholar
• Florins A, Gillet N, Asquith B, et al. Cell dynamics and immune response to BLV infection: a unifying model. Front Biosci. 2007;12:1520–1531.
   PubMed Web of Science ®Google Scholar
• Pomier C, Alcaraz MT, Debacq C, et al. Early and transient reverse transcription during primary deltaretroviral infection of sheep. Retrovirology. 2008;5:16.
   Web of Science ®Google Scholar
• Gillet NA, Gutierrez G, Rodriguez SM, et al. Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog. 2013;9(10):e1003687.
   Web of Science ®Google Scholar
• Kettmann R, Marbaix G, Cleuter Y, Portetelle D, Mammerickx M, Burny A. Genomic integration of bovine leukemia provirus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection. Leuk Res. 1980;4(6):509–519.
   Web of Science ®Google Scholar
• Merezak C, Pierreux C, Adam E, et al. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency. J Virol. 2001;75(15):6977–6988.
   Web of Science ®Google Scholar
• Ferrer JF. Bovine lymphosarcoma. Adv Vet Sci Comp Med. 1980;24:1–68.
   PubMedGoogle Scholar
• Merezak C, Reichert M, Van Lint C, et al. Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo. J Virol. 2002;76(10):5034–5042.
   Web of Science ®Google Scholar
• Pierard V, Guiguen A, Colin L, et al. DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein/CRE modulator/activation transcription factor binding. J Biol Chem. 2010;285(25):19434–19449.
   Web of Science ®Google Scholar
• Debacq C, Asquith B, Reichert M, Burny A, Kettmann R, Willems L. Reduced cell turnover in bovine leukemia virus-infected, persistently lymphocytotic cattle. J Virol. 2003;77(24):13073–13083.
   Web of Science ®Google Scholar
• Ferrer JF, Marshak RR, Abt DA, Kenyon SJ. Relationship between lymphosarcoma and persistent lymphocytosis in cattle: a review. J Am Vet Med Assoc. 1979;175(7):705–708.
   Web of Science ®Google Scholar
• Radostitis O, Gay C, Hinchcliff K, Constable P.. Disease associated with viruses and chlamydia I. In: Elsevier, editor. Veterinary Medicine. 10th ed. Elsevier; 2007:1209–1221.
   Google Scholar
• Juliarena MA, Gutierrez SE, Ceriani C. Determination of proviral load in bovine leukemia virus-infected cattle with and without lymphocytosis. Am J Vet Res. 2007;68(11):1220–1225.
   Web of Science ®Google Scholar
• Ferrer JF, Kenyon SJ, Gupta P. Milk of dairy cows frequently contains a leukemogenic virus. Science. 1981;213(4511):1014–1016.
   Web of Science ®Google Scholar
• McClure HM, Keeling ME, Custer RP, Marshak RR, Abt DA, Ferrer JF. Erythroleukemia in two infant chimpanzees fed milk from cows naturally infected with the bovine C-type virus. Cancer Res. 1974;34(10):2745–2757.
   Web of Science ®Google Scholar
• Chung YS, Prior HC, Duffy PF, Rogers RJ, Mackenzie AR. The effect of pasteurisation on bovine leucosis virus-infected milk. Aust Vet J. 1986;63(11):379–380.
   Web of Science ®Google Scholar
• Johnson RK. Bovine leukemia virus and enzootic bovine leukosis. Veterinary Bulletin. 1992;62(4):287–312.
   Google Scholar
• Bender AP, Robison LL, Kashmiri SV, et al. No involvement of bovine leukemia virus in childhood acute lymphoblastic leukemia and non-Hodgkin’s lymphoma. Cancer Res. 1988;48(10):2919–2922.
   Web of Science ®Google Scholar
• Lee J, Kim Y, Kang CS, et al. Investigation of the bovine leukemia virus proviral DNA in human leukemias and lung cancers in Korea. J Korean Med Sci. 2005;20(4):603–606.
   Web of Science ®Google Scholar
• Buehring GC, Philpott SM, Choi KY. Humans have antibodies reactive with Bovine leukemia virus. AIDS Res Hum Retroviruses. 2003;19(12):1105–1113.
   PubMed Web of Science ®Google Scholar
• Onuma M, Tsukiyama K, Ohya KI, Morishima Y, Ohno R. Detection of cross-reactive antibody to BLV p24 in sera of human patients infected with HTLV. Microbiol Immunol. 1987;31(2):131–137.
   Web of Science ®Google Scholar
• Maruyama K, Fukushima T, Mochizuki S. Cross-reactive antibodies to BLV and HTLV in bovine and human hosts with retrovirus infection. Vet Immunol Immunopathol. 1989;22(3):265–273.
   Web of Science ®Google Scholar
• Zandomeni RO, Carrera-Zandomeni M, Esteban E, Ferrer JF. The trans-activating C-type retroviruses share a distinct epitope(s) that induces antibodies in certain infected hosts. J Gen Virol. 1991;72(Pt 9):2113–2119.
   Google Scholar
• Buehring GC, Shen HM, Jensen HM, Choi KY, Sun D, Nuovo G. Bovine leukemia virus DNA in human breast tissue. Emerg Infect Dis. 2014;20(5):772–782.
   PubMed Web of Science ®Google Scholar
• Buehring GC, Shen HM, Jensen HM, Jin DL, Hudes M, Block G. Exposure to bovine leukemia virus is associated with breast cancer: a case-control study. PLoS One. 2015;10(9):e0134304.
   Web of Science ®Google Scholar
• Zhang R, Jiang J, Sun W, et al. Lack of association between bovine leukemia virus and breast cancer in Chinese patients. Breast Cancer Res. 2016;18(1):101.
   Google Scholar
• Gillet NA, Willems L. Whole genome sequencing of 51 breast cancers reveals that tumors are devoid of bovine leukemia virus DNA. Retrovirology. 2016;13:75.
   Web of Science ®Google Scholar
• Tang KW, Alaei-Mahabadi B, Samuelsson T, Lindh M, Larsson E. The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun. 2013;4:2513.
   PubMed Web of Science ®Google Scholar
• Khoury JD, Tannir NM, Williams MD, et al. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol. 2013;87(16):8916–8926.
   Web of Science ®Google Scholar
• Hopkins SG, DiGiacomo RF. Natural transmission of bovine leukemia virus in dairy and beef cattle. Vet Clin North Am Food Anim Pract. 1997;13(1):107–128.
   Web of Science ®Google Scholar
• Lassauzet ML, Thurmond MC, Johnson WO, Holmberg CA. Factors associated with in utero or periparturient transmission of bovine leukemia virus in calves on a California dairy. Can J Vet Res. 1991;55(3):264–268.
   Web of Science ®Google Scholar
• Romero CH, Cruz GB, Rowe CA. Transmission of bovine leukaemia virus in milk. Trop Anim Health Prod. 1983;15(4):215–218.
   Web of Science ®Google Scholar
• Juliarena MA, Barrios CN, Ceriani MC, Esteban EN. Hot topic: bovine leukemia virus (BLV)-infected cows with low proviral load are not a source of infection for BLV-free cattle. J Dairy Sci. 2016;99(6):4586–4589.
   Web of Science ®Google Scholar
• Ooshiro M, Konnai S, Katagiri Y, et al. Horizontal transmission of bovine leukemia virus from lymphocytotic cattle, and beneficial effects of insect vector control. Vet Rec. 2013;173(21):527.
   Web of Science ®Google Scholar
• Anderson RK, Sorensen DK, Perman V, Dirks VA, Snyder MM, Bearman JE. Selected epizootiologic aspects of bovine leukemia in Minnesota (1961–1965). Am J Vet Res. 1971;32:563–577.
   Google Scholar
• Rhodes JK, Pelzer KD, Johnson YJ. Economic implications of bovine leukemia virus infection in mid-Atlantic dairy herds. J Am Vet Med Assoc. 2003;223(3):346–352.
   Web of Science ®Google Scholar
• Wu MC, Shanks RD, Lewin HA. Milk and fat production in dairy cattle influenced by advanced subclinical bovine leukemia virus infection. Proc Natl Acad Sci U S A. 1989;86(3):993–996.
   Web of Science ®Google Scholar
• Pollari FL, Wangsuphachart VL, DiGiacomo RF, Evermann JF. Effects of bovine leukemia virus infection on production and reproduction in dairy cattle. Can J Vet Res. 1992;56(4):289–295.
   Web of Science ®Google Scholar
• Callebaut I, Voneche V, Mager A, et al. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51. J Virol. 1993;67(9):5321–5327.
   Web of Science ®Google Scholar
• Jacobs RM, Heeney JL, Godkin MA, et al. Production and related variables in bovine leukaemia virus-infected cows. Vet Res Commun. 1991;15(6):463–474.
   Web of Science ®Google Scholar
• Kale M, Bulut O, Yapk O, et al. Effects of subclinical bovine leukemia virus infection on some production parameters in a dairy farm in southern Turkey. J S Afr Vet Assoc. 2007;78(3):130–132.
   Web of Science ®Google Scholar
• Tiwari A, VanLeeuwen JA, Dohoo IR, et al. Production effects of pathogens causing bovine leukosis, bovine viral diarrhea, paratuberculosis, and neosporosis. J Dairy Sci. 2007;90(2):659–669.
   Web of Science ®Google Scholar
• Sorge US, Lissemore K, Cantin R, Kelton DF. Short communication: Milk ELISA status for bovine leukosis virus infection is not associated with milk production in dairy cows. J Dairy Sci. 2011;94(10):5062–5064.
   Web of Science ®Google Scholar
• Erskine RJ, Bartlett PC, Byrem TM, Render CL, Febvay C, Houseman JT. Association between bovine leukemia virus, production, and population age in Michigan dairy herds. J Dairy Sci. 2012;95(2):727–734.
   Web of Science ®Google Scholar
• Ott SL, Johnson R, Wells SJ. Association between bovine-leukosis virus seroprevalence and herd-level productivity on US dairy farms. Prev Vet Med. 2003;61(4):249–262.
   Web of Science ®Google Scholar
• Norby B, Bartlett PC, Byrem TM, Erskine RJ. Effect of infection with bovine leukemia virus on milk production in Michigan dairy cows. J Dairy Sci. 2016;99(3):2043–2052.
   Web of Science ®Google Scholar
• Yang Y, Fan W, Mao Y, et al. Bovine leukemia virus infection in cattle of China: association with reduced milk production and increased somatic cell score. J Dairy Sci. 2016;99(5):3688–3697.
   Web of Science ®Google Scholar
• Nekouei O, VanLeeuwen J, Stryhn H, Kelton D, Keefe G. Lifetime effects of infection with bovine leukemia virus on longevity and milk production of dairy cows. Prev Vet Med. 2016;133:1–9.
   Web of Science ®Google Scholar
• Da Y, Shanks RD, Stewart JA, Lewin HA. Milk and fat yields decline in bovine leukemia virus-infected Holstein cattle with persistent lymphocytosis. Proc Natl Acad Sci U S A. 1993;90(14):6538–6541.
   Web of Science ®Google Scholar
• Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 1997;389(6649):349–352.
   PubMed Web of Science ®Google Scholar
• Rotili D, Simonetti G, Savarino A, Palamara AT, Migliaccio AR, Mai A. Non-cancer uses of histone deacetylase inhibitors: effects on infectious diseases and beta-hemoglobinopathies. Curr Top Med Chem. 2009;9(3):272–291.
   PubMed Web of Science ®Google Scholar
• Beumer JH, Tawbi H. Role of histone deacetylases and their inhibitors in cancer biology and treatment. Curr Clin Pharmacol. 2010;5(3):196–208.
   Google Scholar
• De Souza C, Chatterji BP. HDAC inhibitors as novel anti-cancer therapeutics. Recent Pat Anticancer Drug Discov. 2015;10(2):145–162.
   PubMed Web of Science ®Google Scholar
• Moog C, Kuntz-Simon G, Caussin-Schwemling C, Obert G. Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels. J Gen Virol. 1996;77 (Pt 9):1993–1999.
   Google Scholar
• Chen WY, Townes TM. Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. Proc Natl Acad Sci U S A. 2000;97(1):377–382.
   PubMed Web of Science ®Google Scholar
• Lehrman G, Hogue IB, Palmer S, et al. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet. 2005;366(9485):549–555.
   PubMed Web of Science ®Google Scholar
• Lezin A, Gillet N, Olindo S, et al. Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients. Blood. 2007;110(10):3722–3728.
   PubMed Web of Science ®Google Scholar
• Afonso PV, Mekaouche M, Mortreux F, et al. Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood. 2010;116(19):3802–3808.
   Web of Science ®Google Scholar
• Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem. 2001;276(39):36734–36741.
   PubMed Web of Science ®Google Scholar
• Achachi A, Florins A, Gillet N, et al. Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc Natl Acad Sci U S A. 2005;102(29):10309–10314.
   Web of Science ®Google Scholar
• Gillet N, Vandermeers F, de Brogniez A, et al. Chemoresistance to valproate treatment of bovine leukemia virus-infected sheep; Identification of improved HDAC inhibitors. Pathogens. 2012;1(2):65–82.
   Google Scholar
• Olindo S, Belrose G, Gillet N, et al. Safety of long-term treatment of HAM/TSP patients with valproic acid. Blood. 2011;118(24):6306–6309.
   PubMed Web of Science ®Google Scholar
• Sagot-Lerolle N, Lamine A, Chaix ML, et al. Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir. AIDS. 2008;22(10):1125–1129.
   PubMed Web of Science ®Google Scholar
• Archin NM, Cheema M, Parker D, et al. Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection. PLOS ONE. 2010;5(2):e9390.
   PubMed Web of Science ®Google Scholar
• Routy JP, Tremblay CL, Angel JB, et al. Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study. HIV Med. 2012;13(5):291–296.
   PubMed Web of Science ®Google Scholar
• Boostani R, Vakili R, Hosseiny SS, et al. Triple therapy with prednisolone, pegylated interferon and sodium valproate improves clinical outcome and reduces human T-cell leukemia virus type 1 (HTLV-1) proviral load, tax and HBZ mRNA expression in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Neurotherapeutics. 2015;12(4):887–895.
   Web of Science ®Google Scholar
• Darcis G, Kula A, Bouchat S, et al. An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression. PLoS Pathog. 2015;11(7): e1005063.
   PubMed Web of Science ®Google Scholar
• Callebaut I, Mornon JP, Burny A, Portetelle D. The bovine leukemia virus (BLV) envelope glycoprotein gp51 as a general model for the design of a subunit vaccine against retroviral infection: mapping of functional sites through immunological and structural data. Leukemia. 1994;8(Suppl 1):S218–S221.
   Google Scholar
• Altaner C, Altanerova V, Ban J, et al. Cell-derived vaccine against bovine leukaemia virus infection. Zentralbl Veterinarmed B. 1988;35(10):736–746.
   Google Scholar
• Altaner C, Ban J, Altanerova V, Janik V. Protective vaccination against bovine leukaemia virus infection by means of cell-derived vaccine. Vaccine. 1991;9(12):889–895.
   Web of Science ®Google Scholar
• Altaner C, Ban J, Altanerova V, Cerny L. Experimental transmission of the bovine leukaemia virus genome by cell contact. Folia Biol (Praha). 1987;33(6):400–409.
   Web of Science ®Google Scholar
• Miller JM, Van Der Maaten MJ. Evaluation of an inactivated bovine leukemia virus preparation as an immunogen in cattle. Ann Rech Vet. 1978;9(4):871–877.
   Google Scholar
• Fukuyama S, Kodama K, Hirahara T, et al. Protection against bovine leukemia virus infection by use of inactivated vaccines in cattle. J Vet Med Sci. 1993;55(1):99–106.
   Web of Science ®Google Scholar
• Burkhardt H, Rosenthal S, Wittmann W, et al. [Immunization of young cattle with gp51 of the bovine leukosis virus and the subsequent experimental infection]. Arch Exp Veterinarmed. 1989;43(6):933–942.
   Google Scholar
• Cherney TM, Schultz RD. Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes. Am J Vet Res. 1996;57(6):812–818.
   Web of Science ®Google Scholar
• Ohishi K, Suzuki H, Yamamoto T, et al. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV ENV recombinant: association with cell-mediated immunity. J Gen Virol. 1991;72(8):1887–1892.
   Google Scholar
• Ohishi K, Suzuki H, Yasutomi Y, et al. Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccinia virus: their role in the suppression of BLV replication. Microbiol Immunol. 1992;36(12):13171323.
   Web of Science ®Google Scholar
• Ohishi K, Ikawa Y. T cell-mediated destruction of bovine leukemia virus-infected peripheral lymphocytes by bovine leukemia virus env-vaccinia recombinant vaccine. AIDS Res Hum Retroviruses. 1996;12(5):393–398.
   Web of Science ®Google Scholar
• Gatei MH, Naif HM, Kumar S, et al. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51–70. J Virol. 1993;67(4):1803–1810.
   Web of Science ®Google Scholar
• Okada K, Ikeyama S, Ohishi K, et al. Involvement of CD8+ T cells in delayed-type hypersensitivity responses against bovine leukemia virus (BLV) induced in sheep vaccinated with recombinant vaccinia virus expressing BLV envelope glycoprotein. Vet Pathol. 1993;30(2):104–110.
   Web of Science ®Google Scholar
• Ohishi K, Kabeya H, Amanuma H, Onuma M. Peptide-based bovine leukemia virus (BLV) vaccine that induces BLV-Env specific Th-1 type immunity. Leukemia. 1997;11(Suppl 3):223–226.
   Google Scholar
• Hislop AD, Good MF, Mateo L, et al. Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge. Nat Med. 1998;4(10):1193–1196.
   Web of Science ®Google Scholar
• Portetelle D, Limbach K, Burny A, et al. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection. Vaccine. 1991;9(3):194–200.
   Web of Science ®Google Scholar
• Pyeon D, Splitter GA. Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis. J Virol. 1998;72(8):6917–6921.
   Web of Science ®Google Scholar
• Yakobson B, Brenner J, Ungar-Waron H, Trainin Z. Cellular immune response cytokine expression during the initial stage of bovine leukemia virus (BLV) infection determines the disease progression to persistent lymphocytosis. Comp Immunol Microbiol Infect Dis. 2000;23(3):197–208.
   Web of Science ®Google Scholar
• Usui T, Konnai S, Ohashi K, Onuma M. Interferon-gamma expression associated with suppression of bovine leukemia virus at the early phase of infection in sheep. Vet Immunol Immunopathol. 2007;115(1–2):17–23.
   Web of Science ®Google Scholar
• Mateo L, Gardner J, Suhrbier A. Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T cell-based vaccine. AIDS Res Hum Retroviruses. 2001;17(15):1447–1453.
   Web of Science ®Google Scholar
• Brillowska A, Dabrowski S, Rulka J, Kubis P, Buzala E, Kur J. Protection of cattle against bovine leukemia virus (BLV) infection could be attained by DNA vaccination. Acta Biochim Pol. 1999;46(4):971–976.
   Web of Science ®Google Scholar
• Usui T, Konnai S, Tajima S, et al. Protective effects of vaccination with bovine leukemia virus (BLV) Tax DNA against BLV infection in sheep. J Vet Med Sci. 2003;65(11):1201–1205.
   Web of Science ®Google Scholar
• Derse D, Martarano L. Construction of a recombinant bovine leukemia virus vector for analysis of virus infectivity. J Virol. 1990;64(1):401–405.
   Web of Science ®Google Scholar
• Milan D, Nicolas JF. Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus. J Virol. 1991;65(4):1938–1945.
   Web of Science ®Google Scholar
• Boris-Lawrie K, Altanerova V, Altaner C, Kucerova L, Temin HM. In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex. J Virol. 1997;71(2):1514–1520.
   Web of Science ®Google Scholar
• Kerkhofs P, Gatot JS, Knapen K, et al. Long-term protection against bovine leukaemia virus replication in cattle and sheep. J Gen Virol. 2000;81(Pt 4):957–963.
   Google Scholar
• Willems L, Chen G, Portetelle D, Mamoun R, Burny A, Kettmann R. Structural and functional characterization of mutants of the bovine leukemia virus transactivator protein p34. Virology. 1989;171(2):615–618.
   Web of Science ®Google Scholar
• Willems L, Kettmann R, Dequiedt F, et al. In vivo infection of sheep by bovine leukemia virus mutants. J Virol. 1993;67(7):4078–4085.
   Web of Science ®Google Scholar
• Boris-Lawrie K, Temin HM. Genetically simpler bovine leukemia virus derivatives can replicate independently of Tax and Rex. J Virol. 1995;69(3):1920–1924.
   Web of Science ®Google Scholar
• Kucerova L, Altanerova V, Altaner C, Boris-Lawrie K. Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model. J Virol. 1999;73(10):8160–8166.
   Web of Science ®Google Scholar
• Altanerova V, Holicova D, Kucerova L, Altaner C, Lairmore MD, Boris-Lawrie K. Long-term infection with retroviral structural gene vector provides protection against bovine leukemia virus disease in rabbits. Virology. 2004;329(2):434–439.
   Web of Science ®Google Scholar
• Gatot JS, Callebaut I, Mornon JP, et al. Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo. J Biol Chem. 1998;273(21):12870–12880.
   Web of Science ®Google Scholar
• Rodriguez SM, Florins A, Gillet N, et al. Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV. Viruses. 2011;3(7):1210–1248.
   Web of Science ®Google Scholar
• Dequiedt F, Hanon E, Kerkhofs P, et al. Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis. J Virol. 1997;71(1):630–639.
   Web of Science ®Google Scholar
• Reichert M, Cantor GH, Willems L, Kettmann R. Protective effects of a live attenuated bovine leukaemia virus vaccine with deletion in the R3 and G4 genes. J Gen Virol. 2000;81(Pt 4):965–969.
   Google Scholar
• Asfaw Y, Tsuduku S, Konishi M, et al. Distribution and superinfection of bovine leukemia virus genotypes in Japan. Arch Virol. 2005;150(3):493–505.
   Web of Science ®Google Scholar
• Gutierrez G, Rodriguez SM, de Brogniez A, et al. Vaccination against delta-retroviruses: the bovine leukemia virus paradigm. Viruses. 2014;6(6):2416–2427.
   PubMed Web of Science ®Google Scholar
• Dong B, Silverman RH, Kandel ES. A natural human retrovirus efficiently complements vectors based on murine leukemia virus. PLoS One. 2008;3(9):e3144.
   Web of Science ®Google Scholar
• Lee SW, Markham PF, Coppo MJ, et al. Attenuated vaccines can recombine to form virulent field viruses. Science. 2012;337(6091):188.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Inoue E, Mori H, Osawa Y, Okazaki K. Delayed-onset enzootic bovine leukosis possibly caused by superinfection with bovine leukemia virus mutated in the pol gene. Arch Virol. 2015;160(8):2087–2091.
   Web of Science ®Google Scholar
• Iwabu Y, Goto T, Tsuji S, et al. Superinfection of human immunodeficiency virus type 1 (HIV-1) to cell clone persistently infected with defective virus induces production of highly cytopathogenic HIV-1. Microbes Infect. 2006;8(7):1773–1782.
   Web of Science ®Google Scholar
• Iwabu Y, Mizuta H, Kawase M, Kameoka M, Goto T, Ikuta K. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination. Microbes Infect. 2008;10(5):504–513.
   Web of Science ®Google Scholar
• Ferrer JF. Bovine leukosis: natural transmission and principles of control. J Am Vet Med Assoc. 1979;175(12):1281–1286.
   Web of Science ®Google Scholar
• DiGiacomo RF. The epidemiology and control of bovine leukemia virus infection. Veterinary Medicine. 1992;87:248–257.
   Google Scholar
• Bartlett PC, Sordillo LM, Byrem TM, et al. Options for the control of bovine leukemia virus in dairy cattle. J Am Vet Med Assoc. 2014;244(8):914–922.
   Web of Science ®Google Scholar
• Eaglesome MD, Mitchell D, Betteridge KJ, et al. Transfer of embryos from bovine leukaemia virus-infected cattle to uninfected recipients: preliminary results. Vet Rec. 1982;111(6):122–123.
   Web of Science ®Google Scholar
• DiGiacomo RF, Studer E, Evermann JF, Evered J. Embryo transfer and transmission of bovine leukosis virus in a dairy herd. J Am Vet Med Assoc. 1986;188(8):827–828.
   Web of Science ®Google Scholar
• DiGiacomo RF, McGinnis LK, Studer E, Evermann JF. Failure of embryo transfer to transmit BLV in a dairy herd. Vet Rec. 1990;127(18):456.
   Web of Science ®Google Scholar
• Suh GH, Lee JC, Lee CY, et al. Establishment of a bovine leukemia virus-free dairy herd in Korea. J Vet Sci. 2005;6(3):227–230.
   Google Scholar
• Shettigara PT, Samagh BS, Lobinowich EM. Control of bovine leukemia virus infection in dairy herds by agar gel immunodiffusion test and segregation of reactors. Can J Vet Res. 1989;53(1):108–110.
   Web of Science ®Google Scholar
• Lassauzet ML, Johnson WO, Thurmond MC, Stevens F. Protection of colostral antibodies against bovine leukemia virus infection in calves on a California dairy. Can J Vet Res. 1989;53(4):424–430.
   Web of Science ®Google Scholar
• Nagy DW, Tyler JW, Kleiboeker SB. Decreased periparturient transmission of bovine leukosis virus in colostrum-fed calves. J Vet Intern Med. 2007;21(5):1104–1107.
   Web of Science ®Google Scholar
• Van Der Maaten MJ, Miller JM, Schmerr MJ. Effect of colostral antibody on bovine leukemia virus infection of neonatal calves. Am J Vet Res. 1981;42(9):1498–1500.
   Web of Science ®Google Scholar
• Sprecher DJ, Pelzer KD, Lessard P. Possible effect of altered management practices on seroprevalence of bovine leukemia virus in heifers of a dairy herd with history of high prevalence of infection. J Am Vet Med Assoc. 1991;199(5):584–588.
   Web of Science ®Google Scholar
• Gutiérrez SE, Esteban EN, Lützelschwab CM, Juliarena MA.. Major histocompatibility complex-associated resistance to infectious diseases: the case of bovine leukemia virus infection. In: Abubakar M, editor. Trends and Advances in Veterinary Genetics. Croatia: InTech; 2017.
   Google Scholar
• Lewin HA. Disease resistance and immune response genes in cattle: strategies for their detection and evidence of their existence. J Dairy Sci. 1989;72(5):1334–1348.
   Web of Science ®Google Scholar
• Xu A, van Eijk MJ, Park C, Lewin HA. Polymorphism in BoLA-DRB3 exon 2 correlates with resistance to persistent lymphocytosis caused by bovine leukemia virus. J Immunol. 1993;151(12):6977–6985.
   Web of Science ®Google Scholar
• Zanotti M, Poli G, Ponti W, et al. Association of BoLA class II haplotypes with subclinical progression of bovine leukaemia virus infection in Holstein-Friesian cattle. Anim Genet. 1996;27(5):337–341.
   Web of Science ®Google Scholar
• IPD. Immuno Polymorphism Database - MHC Database. BoLA Nomenclature, Cattle, BoLA DRB3. Available from https://www.ebi.ac.uk/cgi-bin/ipd/mhc/view_nomenclature.cgi?bola.drb3. Accessed July 05, 2016.
   Google Scholar
• Mirsky ML, Olmstead C, Da Y, Lewin HA. Reduced bovine leukaemia virus proviral load in genetically resistant cattle. Anim Genet. 1998;29(4):245–252.
   Web of Science ®Google Scholar
• Juliarena MA, Poli M, Sala L, et al. Association of BLV infection profiles with alleles of the BoLA-DRB3.2 gene. Anim Genet. 2008;39(4):432–438.
   Web of Science ®Google Scholar
• Miyasaka T, Takeshima SN, Jimba M, et al. Identification of bovine leukocyte antigen class II haplotypes associated with variations in bovine leukemia virus proviral load in Japanese Black cattle. Tissue Antigens. 2012;81(2):72–82.
   Google Scholar
• Esteban EN, Poli M, Poiesz B, et al. Bovine leukemia virus (BLV), proposed control and eradication programs by marker assisted breeding of genetically resistant cattle. In: Rechi LJ, editor. Animal Genetics. Hauppauge, NY: Nova Science Publishers, Inc.; 2009:107–130.
   Google Scholar
• Juliarena MA, Poli M, Ceriani C, et al. Antibody response against three widespread bovine viruses is not impaired in Holstein cattle carrying bovine leukocyte antigen DRB3.2 alleles associated with bovine leukemia virus resistance. J Dairy Sci. 2009;92(1):375–381.
   Web of Science ®Google Scholar
• Juliarena M. Aportes al estudio del rol del virus y del hospedador en el perfil de infección causado por el virus de la leucosis bovina. Tesis Doctoral. FCV-UNCPBA. 2008.
   Google Scholar
• Miyasaka T, Takeshima SN, Sentsui H, Aida Y. Identification and diversity of bovine major histocompatibility complex class II haplotypes in Japanese Black and Holstein cattle in Japan. J Dairy Sci. 2012;95(1):420–431.
   PubMed Web of Science ®Google Scholar
• Dietz AB, Cohen ND, Timms L, Kehrli ME, Jr. Bovine lymphocyte antigen class II alleles as risk factors for high somatic cell counts in milk of lactating dairy cows. J Dairy Sci. 1997;80(2):406–412.
   Web of Science ®Google Scholar
• Rupp R, Hernandez A, Mallard BA. Association of bovine leukocyte antigen (BoLA) DRB3.2 with immune response, mastitis, and production and type traits in Canadian Holsteins. J Dairy Sci. 2007;90(2):1029–1038.
   PubMed Web of Science ®Google Scholar
• Sharif S, Mallard BA, Wilkie BN, et al. Associations of the bovine major histocompatibility complex DRB3 (BoLA-DRB3) alleles with occurrence of disease and milk somatic cell score in Canadian dairy cattle. Anim Genet. 1998;29(3):185-193.
   Web of Science ®Google Scholar
• Nassiry MR, Shahroodi FE, Mosafer J, et al. Analysis and frequency of bovine lymphocyte antigen (BoLA-DRB3) alleles in Iranian Holstein cattle. Genetika. 2005;41(6):817–822.
   PubMedGoogle Scholar
• Lützelschwab CM, Forletti A, Cepeda R, Esteban EN, Confalonieri O, Gutiérrez SE. Co-infection with Mycobacterium bovis does not alter the response to bovine leukemia virus in BoLA DRB3*0902, genetically resistant cattle. Res Vet Sci. 2016;109:10–16.
   Web of Science ®Google Scholar
• Forletti A, Juliarena MA, Ceriani C, Amadio AF, Esteban E, Gutierrez SE. Identification of cattle carrying alleles associated with resistance and susceptibility to the bovine leukemia virus progression by real-time PCR. Res Vet Sci. 2013;95(3):991–995.
   Web of Science ®Google Scholar